MED
MED
NYSE · Consumer products

Medifast Inc

$10.20
+0.01 (+0.10%)
As of Apr 1, 2:56 PM ET ·
Financial Highlights (FY 2026)
Revenue
388.54M
Net Income
-18,805,287
Gross Margin
71.3%
Profit Margin
-4.8%
Rev Growth
-37.7%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 71.3% 71.3% 56.0% 56.0%
Operating Margin -3.7% -3.3% 16.6% 19.4%
Profit Margin -4.8% -4.6% 15.1% 16.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 388.54M 624.06M 15.63M 13.56M
Gross Profit 277.15M 445.14M 8.76M 7.60M
Operating Income -14,298,263 -20,668,867 2.60M 2.64M
Net Income -18,805,287 -27,183,999 2.36M 2.26M
Gross Margin 71.3% 71.3% 56.0% 56.0%
Operating Margin -3.7% -3.3% 16.6% 19.4%
Profit Margin -4.8% -4.6% 15.1% 16.7%
Rev Growth -37.7% -37.7% +0.8% +24.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 67.55M 61.71M
Total Equity 104.54M 106.99M
D/E Ratio 0.65 0.58
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 3.11M 4.74M 4.67M 3.57M
Free Cash Flow 2.91M 2.77M